Form 4: Recursion Pharmaceuticals COO Tina Marriott Executes Stock Option and Sells Shares Under 10b5-1 Plan

Tina Marriott, President and COO of Recursion Pharmaceuticals, exercised stock options and sold 6,000 shares of Class A Common Stock at an average price of $7.215 per share on June 27, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On June 27, 2024, Tina Marriott, the President and COO of Recursion Pharmaceuticals, exercised stock options to acquire 6,000 shares of Class A Common Stock at a price of $1.06 per share.
• Simultaneously, Marriott sold 6,000 shares of Class A Common Stock at a weighted average price of $7.215, with individual sales ranging from $6.91 to $7.575.
• These transactions were executed under a pre-arranged 10b5-1 trading plan established on March 1, 2024.
• Following these transactions, Marriott directly owns 535,457 shares of Class A Common Stock.
• Marriott also holds options to purchase a total of 1,267,049 shares of Class A Common Stock at various exercise prices and expiration dates.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports transactions under a pre-existing plan, which doesn't necessarily indicate positive or negative sentiment about the company's prospects.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, which can mitigate concerns about insider trading.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, although the 10b5-1 plan mitigates this concern.

Industry Context

Executive stock transactions are common and are often scrutinized by investors to gauge management's confidence in the company's future prospects. The use of a 10b5-1 plan provides transparency and reduces the potential for accusations of insider trading.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
• The vesting schedules of the options are typical, with vesting occurring over several years.
• The use of 10b5-1 trading plans is a common practice among corporate executives to manage their stock holdings in a compliant manner.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the potential dilution from the exercised options and the sale of shares.

Key Dates